These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
553 related articles for article (PubMed ID: 28361372)
1. State-of-the-Art: a Review of Cardiovascular Effects of Testosterone Replacement Therapy in Adult Males. Elsherbiny A; Tricomi M; Bhatt D; Dandapantula HK Curr Cardiol Rep; 2017 Apr; 19(4):35. PubMed ID: 28361372 [TBL] [Abstract][Full Text] [Related]
2. Hypogonadism and Testosterone Therapy: Associations With Cardiovascular Risk. Maganty A; Osterberg EC; Ramasamy R Am J Mens Health; 2015 Jul; 9(4):340-4. PubMed ID: 24972716 [TBL] [Abstract][Full Text] [Related]
3. Cardiovascular benefits and risks of testosterone replacement therapy in older men with low testosterone. Chrysant SG; Chrysant GS Hosp Pract (1995); 2018 Apr; 46(2):47-55. PubMed ID: 29478348 [TBL] [Abstract][Full Text] [Related]
4. Testosterone replacement therapy and cardiovascular events. Çatakoğlu AB; Kendirci M Turk Kardiyol Dern Ars; 2017 Oct; 45(7):664-672. PubMed ID: 28990951 [TBL] [Abstract][Full Text] [Related]
5. Testosterone Replacement Therapy and Mortality in Older Men. Hackett GI Drug Saf; 2016 Feb; 39(2):117-30. PubMed ID: 26482385 [TBL] [Abstract][Full Text] [Related]
6. Testosterone therapy in hypogonadal patients and the associated risks of cardiovascular events. Kharaba ZJ; Buabeid MA; Ibrahim NA; Jirjees FJ; Obaidi HJA; Kaddaha A; Khajehkarimoddini L; Alfoteih Y Biomed Pharmacother; 2020 Sep; 129():110423. PubMed ID: 32570122 [TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy. Coward RM; Simhan J; Carson CC BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450 [TBL] [Abstract][Full Text] [Related]
8. Testosterone Replacement Therapy and Cardiovascular Disease: Balancing Safety and Risks in Hypogonadal Men. Blackwell K; Blackwell M; Blackwell T Curr Cardiol Rep; 2023 Oct; 25(10):1157-1163. PubMed ID: 37733143 [TBL] [Abstract][Full Text] [Related]
9. EMAS position statement: Testosterone replacement therapy in older men. Kanakis GA; Pofi R; Goulis DG; Isidori AM; Armeni E; Erel CT; Fistonić I; Hillard T; Hirschberg AL; Meczekalski B; Mendoza N; Mueck AO; Simoncini T; Stute P; van Dijken D; Rees M; Lambrinoudaki I Maturitas; 2023 Dec; 178():107854. PubMed ID: 37845136 [TBL] [Abstract][Full Text] [Related]
10. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels. Blick G Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769 [TBL] [Abstract][Full Text] [Related]
11. Testosterone Therapy: What We Have Learned From Trials. Corona G; Torres LO; Maggi M J Sex Med; 2020 Mar; 17(3):447-460. PubMed ID: 31928918 [TBL] [Abstract][Full Text] [Related]
12. Testosterone in men with hypogonadism and high cardiovascular risk, Pros. Rosano GM; Vitale C; Fini M Endocrine; 2015 Nov; 50(2):320-5. PubMed ID: 25749966 [TBL] [Abstract][Full Text] [Related]
13. Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME). Maggi M; Wu FC; Jones TH; Jackson G; Behre HM; Hackett G; Martin-Morales A; Balercia G; Dobs AS; Arver ST; Maggio M; Cunningham GR; Isidori AM; Quinton R; Wheaton OA; Siami FS; Rosen RC; Int J Clin Pract; 2016 Oct; 70(10):843-852. PubMed ID: 27774779 [TBL] [Abstract][Full Text] [Related]
14. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report. Morrison BF; Reid M; Madden W; Burnett AL Andrology; 2013 Jul; 1(4):576-82. PubMed ID: 23606509 [TBL] [Abstract][Full Text] [Related]
15. Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men. Borst SE; Yarrow JF Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1035-42. PubMed ID: 25898953 [TBL] [Abstract][Full Text] [Related]
17. Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME). Rosen RC; Wu F; Behre HM; Porst H; Meuleman EJH; Maggi M; Romero-Otero J; Martinez-Salamanca JI; Jones TH; Debruyne FMJ; Kurth KH; Hackett GI; Quinton R; Stroberg P; Reisman Y; Pescatori ES; Morales A; Bassas L; Cruz N; Cunningham GR; Wheaton OA; J Sex Med; 2017 Sep; 14(9):1104-1115. PubMed ID: 28781213 [TBL] [Abstract][Full Text] [Related]
18. A Pilot Study Using a Web Survey to Identify Characteristics That Influence Hypogonadal Men to Initiate Testosterone Replacement Therapy. Rosen RC; Seftel AD; Ruff DD; Muram D Am J Mens Health; 2018 May; 12(3):567-574. PubMed ID: 26819183 [TBL] [Abstract][Full Text] [Related]
19. Cardiovascular and Cerebrovascular Safety of Testosterone Replacement Therapy Among Aging Men with Low Testosterone Levels: A Cohort Study. Loo SY; Azoulay L; Nie R; Dell'Aniello S; Yu OHY; Renoux C Am J Med; 2019 Sep; 132(9):1069-1077.e4. PubMed ID: 30953635 [TBL] [Abstract][Full Text] [Related]
20. Testosterone replacement therapy in males with erectile dysfunction. Jacob BC J Pharm Pract; 2011 Jun; 24(3):298-306. PubMed ID: 21676853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]